Galectin Therapeutics Inc (GALT)

3.34 -0.03 (-0.89%) USD  |  NASDAQ  |  May 03, 16:00
3.36 +0.02 (+0.60%) Pre-Market: 20:00
More

Galectin Therapeutics EBITDA Margin (Quarterly)

EBITDA Margin (Quarterly) Chart

View EBITDA Margin (Quarterly) for GALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EBITDA Margin (Quarterly) Data

View and export this data back to 2001. Upgrade now.
Date Value
September 30, 2001 --

EBITDA Margin Definition

EBITDA Margin (TTM) is trailing twelve month earnings before interest, taxes, depreciation and amortization divided by trailing twelve month net sales.

Read full definition.

EBITDA Margin (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (Quarterly) Benchmarks

Madrigal Pharmaceuticals Inc --
Viking Therapeutics Inc --
89bio Inc --
Terns Pharmaceuticals Inc --
Enanta Pharmaceuticals Inc Upgrade